Chinese- REPORT SUMMARY
- TABLE OF CONTENTS
-
The report details the trend, potential and market size of Breakthrough Therapy (BT) Designation market, and analyzes the current situation and prospects of the market from both qualitative and quantitative aspects, which can be roughly divided into three parts.
The first part (Chapter1-7) mainly covers the qualitative analysis of Breakthrough Therapy (BT) Designationmarket, defines the market attractiveness level of Breakthrough Therapy (BT) Designation market through Porter's Five Forces Analysis, and summarizes the different factors in the overall environment through PEST analysis. Understand the distribution of industrial chain value in each link of industrial chain through the analysis of industrial chain structure. Thus estimate the market space of each link.
The second part (Chapter8-12), based on the segmentation of Breakthrough Therapy (BT) Designation industry, describes the types of Breakthrough Therapy (BT) Designation market, the applications of major players and the market size, and deeply analyzes the current situation of the global Breakthrough Therapy (BT) Designation market and the development prospects and opportunities of Breakthrough Therapy (BT) Designation industry.
The third part (Chapter14-15) includes the market positions of the major players and information on the market participants, which will help you gain a comprehensive understanding of the current competitive situation and potential growth opportunities in the market.
As COVID-19 continues to impact the global economy in 2022, the report also considers the short - and long-term impacts of COVID-19 on the global Breakthrough Therapy (BT) Designation market in Chapter 13.
By Player:
GlaxoSmithKline plc
Regeneron
Pfizer, Inc
AbbVie, Inc
Novartis AG
Acadia Pharmaceuticals, Inc
Bristol-Myers Squibb Company
By Type:
Oncology
Infectious Diseases
Rare Diseases
Autoimmune Diseases
Pulmonary Diseases
Neurological Disorders
Others
By End-User:
Hospital
Clinic
Research Institute
Laboratories
By Geography:
-
United States
-
Europe
-
China
-
Japan
-
India
-
South Korea
TABLE OF CONTENT
1 Introduction
-
1.1 Market Definition
-
1.2 Market Segment Analysis
-
1.3 Market Size 2022
-
1.4 Breakthrough Therapy (BT) Designation Market Outlook: Forecast for 2022 - 2028
-
1.5 Pricing Analysis
2 Executive Summary
3 Breakthrough Therapy (BT) Designation Market Lineage Outlook
-
3.1 Parent Market Outlook
-
3.2 Related/Ancillary Market Outlook
-
3.3 Penetration & Growth Prospect Mapping, 2022
4 Market Analysis Tools: Porter's Five Forces
-
4.1 Supplier Power
-
4.2 Buyer Power
-
4.3 Substitution Threat
-
4.4 Threat of New Entrants
-
4.5 Competitive Rivalry
5 Breakthrough Therapy (BT) Designation Industry Analysis - PEST (Political & Legal, Economic, Social, and Technological)
-
5.1 Political/Legal Landscape
-
5.2 Economic Landscape
-
5.3 Social Landscape
-
5.4 Technology Landscape
6 Breakthrough Therapy (BT) Designation Market - Value Chain Analysis
-
6.1 Industry's Value Chain Analysis
-
6.2 Product Life Cycle
-
6.3 User Perspective Analysis
7 Region and Country-wise Breakthrough Therapy (BT) Designation Market Analysis and Outlook to 2022
-
7.1 Global Breakthrough Therapy (BT) Designation Consumption (2017-2022)
-
7.2 United States Breakthrough Therapy (BT) Designation Consumption (2017-2022)
-
7.3 Europe Breakthrough Therapy (BT) Designation Consumption (2017-2022)
-
7.4 China Breakthrough Therapy (BT) Designation Consumption (2017-2022)
-
7.5 Japan Breakthrough Therapy (BT) Designation Consumption (2017-2022)
-
7.6 India Breakthrough Therapy (BT) Designation Consumption (2017-2022)
-
7.7 South Korea Breakthrough Therapy (BT) Designation Consumption (2017-2022)
8 Region and Country-wise Breakthrough Therapy (BT) Designation Market Analysis and Outlook to 2028
-
8.1 Global Breakthrough Therapy (BT) Designation Consumption Forecast (2022-2028)
-
8.2 United States Breakthrough Therapy (BT) Designation Consumption Forecast (2022-2028)
-
8.3 Europe Breakthrough Therapy (BT) Designation Consumption Forecast (2022-2028)
-
8.4 China Breakthrough Therapy (BT) Designation Consumption Forecast (2022-2028)
-
8.5 Japan Breakthrough Therapy (BT) Designation Consumption Forecast (2022-2028)
-
8.6 India Breakthrough Therapy (BT) Designation Consumption Forecast (2022-2028)
-
8.7 South Korea Breakthrough Therapy (BT) Designation Consumption Forecast (2022-2028)
9 Global Breakthrough Therapy (BT) Designation Market Outlook by Types and Applications to 2022
-
9.1 Global Breakthrough Therapy (BT) Designation Consumption and Growth Rate by Type (2017-2022)
-
9.1.1 Global Oncology Consumption and Growth Rate (2017-2022)
-
9.1.2 Global Infectious Diseases Consumption and Growth Rate (2017-2022)
-
9.1.3 Global Rare Diseases Consumption and Growth Rate (2017-2022)
-
9.1.4 Global Autoimmune Diseases Consumption and Growth Rate (2017-2022)
-
9.1.5 Global Pulmonary Diseases Consumption and Growth Rate (2017-2022)
-
9.1.6 Global Neurological Disorders Consumption and Growth Rate (2017-2022)
-
9.1.7 Global Others Consumption and Growth Rate (2017-2022)
-
9.2 Global Breakthrough Therapy (BT) Designation Consumption and Growth Rate by Application (2017-2022)
-
9.2.1 Global Hospital Consumption and Growth Rate (2017-2022)
-
9.2.2 Global Clinic Consumption and Growth Rate (2017-2022)
-
9.2.3 Global Research Institute Consumption and Growth Rate (2017-2022)
-
9.2.4 Global Laboratories Consumption and Growth Rate (2017-2022)
10 Global Breakthrough Therapy (BT) Designation Market Outlook by Types and Applications to 2028
-
10.1 Global Breakthrough Therapy (BT) Designation Consumption Forecast and Growth Rate by Type (2022-2028)
-
10.1.1 Global Oncology Consumption Forecast and Growth Rate (2022-2028)
-
10.1.2 Global Infectious Diseases Consumption Forecast and Growth Rate (2022-2028)
-
10.1.3 Global Rare Diseases Consumption Forecast and Growth Rate (2022-2028)
-
10.1.4 Global Autoimmune Diseases Consumption Forecast and Growth Rate (2022-2028)
-
10.1.5 Global Pulmonary Diseases Consumption Forecast and Growth Rate (2022-2028)
-
10.1.6 Global Neurological Disorders Consumption Forecast and Growth Rate (2022-2028)
-
10.1.7 Global Others Consumption Forecast and Growth Rate (2022-2028)
-
10.2 Global Breakthrough Therapy (BT) Designation Consumption Forecast and Growth Rate by Application (2022-2028)
-
10.2.1 Global Hospital Consumption Forecast and Growth Rate (2022-2028)
-
10.2.2 Global Clinic Consumption Forecast and Growth Rate (2022-2028)
-
10.2.3 Global Research Institute Consumption Forecast and Growth Rate (2022-2028)
-
10.2.4 Global Laboratories Consumption Forecast and Growth Rate (2022-2028)
11 Global Breakthrough Therapy (BT) Designation Import and Export Analysis (Top 5 Countries)
-
11.1 Global Breakthrough Therapy (BT) Designation Import by Region (Top 5 Countries) (2017-2028)
-
11.2 Global Breakthrough Therapy (BT) Designation Export by Region (Top 5 Countries) (2017-2028)
12 Coronavirus Disease (COVID-19) Impact
-
12.1 Industry Impact Analysis
-
12.2 Breakthrough Therapy (BT) Designation Market Outlook to 2028 - COVID-19 Affected Forecasts
13 Competition Matrix
-
13.1 Target Markets
-
13.2 Comprehensive Analysis of Products in Competitive Markets
14 Global Breakthrough Therapy (BT) Designation Market Competitive Analysis
-
14.1 GlaxoSmithKline plc
-
14.1.1 GlaxoSmithKline plc Company Details
-
14.1.2 GlaxoSmithKline plc Breakthrough Therapy (BT) Designation Sales, Price, Value and Gross Profit (2017-2022)
-
14.1.3 GlaxoSmithKline plc Breakthrough Therapy (BT) Designation Product and Service
-
14.2 Regeneron
-
14.2.1 Regeneron Company Details
-
14.2.2 Regeneron Breakthrough Therapy (BT) Designation Sales, Price, Value and Gross Profit (2017-2022)
-
14.2.3 Regeneron Breakthrough Therapy (BT) Designation Product and Service
-
14.3 Pfizer, Inc
-
14.3.1 Pfizer, Inc Company Details
-
14.3.2 Pfizer, Inc Breakthrough Therapy (BT) Designation Sales, Price, Value and Gross Profit (2017-2022)
-
14.3.3 Pfizer, Inc Breakthrough Therapy (BT) Designation Product and Service
-
14.4 AbbVie, Inc
-
14.4.1 AbbVie, Inc Company Details
-
14.4.2 AbbVie, Inc Breakthrough Therapy (BT) Designation Sales, Price, Value and Gross Profit (2017-2022)
-
14.4.3 AbbVie, Inc Breakthrough Therapy (BT) Designation Product and Service
-
14.5 Novartis AG
-
14.5.1 Novartis AG Company Details
-
14.5.2 Novartis AG Breakthrough Therapy (BT) Designation Sales, Price, Value and Gross Profit (2017-2022)
-
14.5.3 Novartis AG Breakthrough Therapy (BT) Designation Product and Service
-
14.6 Acadia Pharmaceuticals, Inc
-
14.6.1 Acadia Pharmaceuticals, Inc Company Details
-
14.6.2 Acadia Pharmaceuticals, Inc Breakthrough Therapy (BT) Designation Sales, Price, Value and Gross Profit (2017-2022)
-
14.6.3 Acadia Pharmaceuticals, Inc Breakthrough Therapy (BT) Designation Product and Service
-
14.7 Bristol-Myers Squibb Company
-
14.7.1 Bristol-Myers Squibb Company Company Details
-
14.7.2 Bristol-Myers Squibb Company Breakthrough Therapy (BT) Designation Sales, Price, Value and Gross Profit (2017-2022)
-
14.7.3 Bristol-Myers Squibb Company Breakthrough Therapy (BT) Designation Product and Service
15 Appendix
TABLE OF CHARTS
-
Table Definition of Breakthrough Therapy (BT) Designation
-
Figure Breakthrough Therapy (BT) Designation Picture
-
Table Global Breakthrough Therapy (BT) Designation Market Size and Forecast 2022 - 2028 (USD million)
-
Figure Global Breakthrough Therapy (BT) Designation Market Size and Forecast 2022 - 2028 (USD million)
-
Figure Global Breakthrough Therapy (BT) Designation Market: Year-over-year Growth 2022 - 2028 (%)
-
Table Parent Market Analysis
-
Figure Parent Market Price
-
Table Related/Ancillary Market Outlook Analysis
-
Table Supplier Power Analysis
-
Table Buyer Power Analysis
-
Table Substitution Threat Analysis
-
Table Threat of New Entrants Analysis
-
Table Competitive Rivalry Analysis
-
Figure Global Breakthrough Therapy (BT) Designation Consumption by Country (2017-2022)
-
Figure United States Breakthrough Therapy (BT) Designation Consumption and Growth Rate (2017-2022)
-
Table Europe Breakthrough Therapy (BT) Designation Consumption and Growth Rate (2017-2022)
-
Figure China Breakthrough Therapy (BT) Designation Consumption and Growth Rate (2017-2022)
-
Figure Japan Breakthrough Therapy (BT) Designation Consumption and Growth Rate (2017-2022)
-
Figure India Breakthrough Therapy (BT) Designation Consumption and Growth Rate (2017-2022)
-
Figure South Korea Breakthrough Therapy (BT) Designation Consumption and Growth Rate (2017-2022)
-
Figure Global Breakthrough Therapy (BT) Designation Consumption Forecast by Country (2022-2028)
-
Figure United States Breakthrough Therapy (BT) Designation Consumption Forecast and Growth Rate (2022-2028)
-
Table Europe Breakthrough Therapy (BT) Designation Consumption Forecast and Growth Rate (2022-2028)
-
Figure China Breakthrough Therapy (BT) Designation Consumption Forecast and Growth Rate (2022-2028)
-
Figure Japan Breakthrough Therapy (BT) Designation Consumption Forecast and Growth Rate (2022-2028)
-
Figure India Breakthrough Therapy (BT) Designation Consumption Forecast and Growth Rate (2022-2028)
-
Figure South Korea Breakthrough Therapy (BT) Designation Consumption Forecast and Growth Rate (2022-2028)
-
Figure Global Oncology Consumption and Growth Rate (2017-2022)
-
Figure Global Infectious Diseases Consumption and Growth Rate (2017-2022)
-
Figure Global Rare Diseases Consumption and Growth Rate (2017-2022)
-
Figure Global Autoimmune Diseases Consumption and Growth Rate (2017-2022)
-
Figure Global Pulmonary Diseases Consumption and Growth Rate (2017-2022)
-
Figure Global Neurological Disorders Consumption and Growth Rate (2017-2022)
-
Figure Global Others Consumption and Growth Rate (2017-2022)
-
Figure Global Hospital Consumption and Growth Rate (2017-2022)
-
Figure Global Clinic Consumption and Growth Rate (2017-2022)
-
Figure Global Research Institute Consumption and Growth Rate (2017-2022)
-
Figure Global Laboratories Consumption and Growth Rate (2017-2022)
-
Figure Global Oncology Consumption Forecast and Growth Rate (2022-2028)
-
Figure Global Infectious Diseases Consumption Forecast and Growth Rate (2022-2028)
-
Figure Global Rare Diseases Consumption Forecast and Growth Rate (2022-2028)
-
Figure Global Autoimmune Diseases Consumption Forecast and Growth Rate (2022-2028)
-
Figure Global Pulmonary Diseases Consumption Forecast and Growth Rate (2022-2028)
-
Figure Global Neurological Disorders Consumption Forecast and Growth Rate (2022-2028)
-
Figure Global Others Consumption Forecast and Growth Rate (2022-2028)
-
Figure Global Hospital Consumption Forecast and Growth Rate (2022-2028)
-
Figure Global Clinic Consumption Forecast and Growth Rate (2022-2028)
-
Figure Global Research Institute Consumption Forecast and Growth Rate (2022-2028)
-
Figure Global Laboratories Consumption Forecast and Growth Rate (2022-2028)
-
Table Global Breakthrough Therapy (BT) Designation Import by Region (Top 5 Countries) (2017-2028)
-
Table Global Breakthrough Therapy (BT) Designation Export by Region (Top 5 Countries) (2017-2028)
-
Table GlaxoSmithKline plc (Foundation Year, Company Profile and etc.)
-
Table GlaxoSmithKline plc Breakthrough Therapy (BT) Designation Sales, Price, Value and Gross Profit (2017-2022)
-
Table GlaxoSmithKline plc Breakthrough Therapy (BT) Designation Product and Service
-
Table Regeneron (Foundation Year, Company Profile and etc.)
-
Table Regeneron Breakthrough Therapy (BT) Designation Sales, Price, Value and Gross Profit (2017-2022)
-
Table Regeneron Breakthrough Therapy (BT) Designation Product and Service
-
Table Pfizer, Inc (Foundation Year, Company Profile and etc.)
-
Table Pfizer, Inc Breakthrough Therapy (BT) Designation Sales, Price, Value and Gross Profit (2017-2022)
-
Table Pfizer, Inc Breakthrough Therapy (BT) Designation Product and Service
-
Table AbbVie, Inc (Foundation Year, Company Profile and etc.)
-
Table AbbVie, Inc Breakthrough Therapy (BT) Designation Sales, Price, Value and Gross Profit (2017-2022)
-
Table AbbVie, Inc Breakthrough Therapy (BT) Designation Product and Service
-
Table Novartis AG (Foundation Year, Company Profile and etc.)
-
Table Novartis AG Breakthrough Therapy (BT) Designation Sales, Price, Value and Gross Profit (2017-2022)
-
Table Novartis AG Breakthrough Therapy (BT) Designation Product and Service
-
Table Acadia Pharmaceuticals, Inc (Foundation Year, Company Profile and etc.)
-
Table Acadia Pharmaceuticals, Inc Breakthrough Therapy (BT) Designation Sales, Price, Value and Gross Profit (2017-2022)
-
Table Acadia Pharmaceuticals, Inc Breakthrough Therapy (BT) Designation Product and Service
-
Table Bristol-Myers Squibb Company (Foundation Year, Company Profile and etc.)
-
Table Bristol-Myers Squibb Company Breakthrough Therapy (BT) Designation Sales, Price, Value and Gross Profit (2017-2022)
-
Table Bristol-Myers Squibb Company Breakthrough Therapy (BT) Designation Product and Service
-
